Status:
RECRUITING
Immune Response in Patients With Hepatitis B and C Infection
Lead Sponsor:
Mid and South Essex NHS Foundation Trust
Collaborating Sponsors:
Foundation for Liver Research
Conditions:
Hepatitis B
Hepatitis C
Eligibility:
All Genders
18-70 years
Brief Summary
Using peripheral blood mononuclear cells (PBMC) and serum collection from HBV and HCV infected patients in a number of different immunological assays, the investigators hope to identify any changes in...
Detailed Description
Hepatitis B virus (HBV) and C (HCV) are the leading causes of liver disease worldwide. Approximately 400 million people worldwide are chronically infected with HBV world wide and it is estimated that ...
Eligibility Criteria
Inclusion
- Chronic Hepatitis B patients At all stages of infection Treatment naive and previously treated Longitudinal samples from patients treated with antiviral agents and interferon
- Chronic Hepatitis C patients All genotypes - treatment naive and previously treated Longitudinal samples from patients treated with interferon and STATIC therapy
Exclusion
- Coinfection with HIV Coinfection with hepatitis delta Excessive alcohol use Autoimmune liver disease Metabolic liver disease
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT02275221
Start Date
August 1 2013
End Date
December 1 2024
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Basildon Hospital
Basildon, Essex, United Kingdom, SS16 5NL